Tower Research Capital LLC (Trc) Age X Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.33 - $0.74 $816 - $1,830	-2,474 Reduced 18.74%	10,725 $4,000
Q3 2023 Nov 14, 2023	BUY	$0.67 - $0.85 $1,090 - $1,383	1,628 Added 14.07%	13,199 $8,000
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.89 $879 - $1,739	-1,954 Reduced 14.45%	11,571 $10,000
Q1 2023 May 09, 2023	SELL	$0.56 - $0.8 $1,825 - $2,608	-3,260 Reduced 19.42%	13,525 $9,000
Q4 2022 Feb 10, 2023	BUY	$0.54 - $0.68 $2,502 - $3,151	4,635 Added 38.15%	16,785 $9,000
Q3 2022 Nov 10, 2022	BUY	$0.55 - $0.74 $1,332 - $1,793	2,423 Added 24.91%	12,150 $7,000
Q2 2022 Aug 15, 2022	BUY	$0.57 - $1.0 $2,034 - $3,570	3,570 Added 57.98%	9,727 $6,000
Q1 2022 May 12, 2022	BUY	$0.65 - $1.2 $3,013 - $5,563	4,636 Added 304.8%	6,157 $5,000
Q3 2021 Nov 15, 2021	SELL	$0.93 - $1.54 $1,808 - $2,995	-1,945 Reduced 56.12%	1,521 $1,000
Q2 2021 Aug 16, 2021	BUY	$1.14 - $1.77 $2,217 - $3,442	1,945 Added 127.88%	3,466 $5,000
Q1 2021 May 17, 2021	SELL	$1.56 - $2.7 $26,254 - $45,441	-16,830 Reduced 91.71%	1,521 $2,000
Q4 2020 Feb 16, 2021	BUY	$0.8 - $2.56 $13,464 - $43,084	16,830 Added 1106.51%	18,351 $28,000
Q3 2020 Nov 16, 2020	SELL	$0.79 - $1.52 $4,827 - $9,288	-6,111 Reduced 80.07%	1,521 $1,000
Q2 2020 Aug 13, 2020	BUY	$0.68 - $1.13 $4,155 - $6,905	6,111 Added 401.78%	7,632 $7,000
Q4 2019 Feb 07, 2020	BUY	$1.25 - $1.82 $547 - $797	438 Added 40.44%	1,521 $3,000
Q3 2019 Nov 05, 2019	BUY	$1.96 - $3.38 $1,266 - $2,183	646 Added 147.83%	1,083 $2,000
Q2 2019 Aug 13, 2019	SELL	$2.58 - $4.92 $14,832 - $28,285	-5,749 Reduced 92.94%	437 $2,000
Q1 2019 May 14, 2019	BUY	$3.0 - $4.85 $12,975 - $20,976	4,325 Added 232.4%	6,186 $26,000
Q4 2018 Feb 14, 2019	BUY	$2.49 - $5.5 $4,633 - $10,235	1,861 New	1,861 $6,000

Others Institutions Holding AGE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Corsicana & Co.

1K
Shares

$0
0.0% of portfolio

View Full List

About AgeX Therapeutics, Inc.

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

More about AGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account